Discovery’s Interim Results Highlight Strong Growth
Learn how Discovery’s interim results reflect a 22% increase in normalised profit, demonstrating resilience in a fluctuating market.
Life Healthcare Share Price Stumbles Following R2.9bn Liability Adjustment
Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.
Ascendis Health Exits JSE and Positions for Growth
Ascendis Health exits JSE following a strong investor mandate as part of its turnaround strategy aimed at unlocking value.
Aspen Unlocking Value with New Manufacturing Strategies
Understand Aspen Unlocking Value efforts as CEO Stephen Saad addresses the decline in share price and targets business improvements.
Mediclinic AI Strategy Targets R2 Billion Savings Amid Job Freezes
Explore the Mediclinic AI strategy aimed at R2 billion in savings by 2027 through Artificial Intelligence integration.
SA Pharma Sector Unfazed by US Tariffs Impact
The SA pharma sector is unfazed by US tariffs, as key leaders assess the situation, ensuring stability and security in the market.